Announced
Financials
Tags
Pharmaceuticals
Pending
Private
Single Bidder
medical cannabis
Majority
Domestic
medical marijuana
Friendly
Acquisition
Canada
Synopsis
HEXO, a medical cannabis company, agreed to acquire Redecan, a Canadian cannabis company, for $766m. “Redecan’s unwavering focus on the consumer, along with lean operating principles and highly efficient automated manufacturing technology, have allowed us to establish a significant presence in the Canadian market. We’ve now entered a phase where scale is key, and our complementary consumer bases, brand portfolios and distribution relationships can enhance financial performance," Will Montour, Redecan Co-Founder.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.